Home
>
National Drug Code (NDC)
>
Pentazocine and naloxone
Pentazocine and naloxone - 0591-0395-01 - (Pentazocine hydrochloride and naloxone hydrochloride)
Drug Information of Pentazocine and naloxone
| Product NDC: | 0591-0395 |
| Proprietary Name: | Pentazocine and naloxone |
| Non Proprietary Name: | Pentazocine hydrochloride and naloxone hydrochloride |
| Active Ingredient(s): | .5; 50 mg/1; mg/1 & nbsp; Pentazocine hydrochloride and naloxone hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pentazocine and naloxone
| Product NDC: | 0591-0395 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074736 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970121 |
Package Information of Pentazocine and naloxone
| Package NDC: | 0591-0395-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0591-0395-01) |
NDC Information of Pentazocine and naloxone
| NDC Code | 0591-0395-01 |
| Proprietary Name | Pentazocine and naloxone |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0591-0395-01) |
| Product NDC | 0591-0395 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pentazocine hydrochloride and naloxone hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19970121 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE |
| Strength Number | .5; 50 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
